1.03789
ChP
JP
NF
Ph. Eur.
EMPROVE® EXPERT
solid
≤0.3 IU/g endotoxin (low)
7 (20 °C, 100 g/L in H2O)
185-187 °C (lit.)
biopharma process and formulation
liquid formulation
parenterals
pharmaceutical
ambient
2-30°C
OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
1S/C12H22O11/c13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12/h4-11,13-20H,1-3H2/t4-,5-,6-,7-,8+,9-,10+,11-,12+/m1/s1
CZMRCDWAGMRECN-UGDNZRGBSA-N
Looking for similar products? Visit Product Comparison Guide
11 - Combustible Solids
WGK 1
Not applicable
Not applicable
Enter Lot Number to search for Certificate of Analysis (COA).
Enter Lot Number to search for Certificate of Quality (COQ).
The Emprove® Program is a system providing comprehensive and thorough documentation of our filters and single-use components, pharma raw materials, and starting materials.
Free of charge - Sign in to download
Available by subscription or for a fee
Available by subscription or for a fee
Nanoparticulate impurities (NPIs) in pharmaceutical-grade sucrose reduce the stability of final protein formulations. Applying a purification process results in a low NPI sucrose, thus mitigating risk during formulation development.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service